Printer Friendly

Bayer obtains United States patent.

Bayer BioScience GmbH (Potsdam, Germany) has patented DNA sequences coding for proteins having the enzymatic activity of an amylosucrase which allows the synthesis of linear .alpha.-1,4 glucans from the substrate sucrose by bacteria, fungi and plants or in cell-free systems. The invention furthermore describes plasmids and bacteria containing these DNA sequences as well as processes for the production of plants and microorganisms capable of intracellularly or extracellularly expressing a polypeptide having amylosucrase activity. The invention furthermore relates to the production of pure fructose using proteins exhibiting the enzymatic activity of amylosucrase. (US 6,818,421)
COPYRIGHT 2004 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Bayer BioScience GmbH
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:4EUGE
Date:Nov 1, 2004
Words:97
Previous Article:Ajinomoto obtains United States patent.
Next Article:Gene-IT introduces sequence information broadcast network.
Topics:


Related Articles
Oxford announces grant of expanded high-throughput proteomics patent.
Bayer Faser. (2002 Expo in Print).
MorphoSys widens scope of United States patent for HuCAL technology.
A U.S. appeals court revives Bayer BioScience's patent claims in a legal dispute with rival Monsanto Co. over technology Monsanto uses in its...

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters